Free Trial Information
BioCentury | Sep 11, 2015
Company News

Management tracks

...COO, a newly created role. Alataris was president, CEO and CCO of medical device company Nevro Corp....
Read More
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...TSX:ENL) 6/4/15 $2,300.00 $17,335.0 $16,585.3 -4% Ocular Therapeutix Inc. (NASDAQ:OCUL) 6/4/15 $70.40 $543.5 $519.5 -4% Nevro Corp....
Read More
BioCentury | Jun 29, 2015
Financial News

Nevro financial update

...Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date announced: 2015-06-23 Note: Nevro raised $36 million...
Read More
BioCentury | Jun 8, 2015
Financial News

Nevro completes follow-on

Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date completed: 2015-06-03 Type: Follow-on Raised: $90 million Shares: 1.8 million Price: $51 Shares after offering: 26.7 million Underwriters: JPMorgan; Morgan Stanley; Leerink Partners; JMP Securities Overallotment:...
Read More
BioCentury | May 25, 2015
Financial News

Nevro proposes follow-on

Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date announced: 2015-05-18 Type: Follow-on To be raised: $75 million Shares: TBD Price prior: $53.12 Underwriters: JPMorgan; Morgan Stanley; Leerink Partners; JMP Securities Overallotment: $30 million Note:...
Read More
BioCentury | Nov 23, 2009
Company News

Neuros Medical management update

...Inc. , Cleveland, Ohio Business: Neurology Hired: Zi-Ping Fang as CTO, formerly chief scientist at Nevro Corp. WIR...
Read More
Items per page:
1 - 6 of 6
BioCentury | Sep 11, 2015
Company News

Management tracks

...COO, a newly created role. Alataris was president, CEO and CCO of medical device company Nevro Corp....
Read More
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...TSX:ENL) 6/4/15 $2,300.00 $17,335.0 $16,585.3 -4% Ocular Therapeutix Inc. (NASDAQ:OCUL) 6/4/15 $70.40 $543.5 $519.5 -4% Nevro Corp....
Read More
BioCentury | Jun 29, 2015
Financial News

Nevro financial update

...Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date announced: 2015-06-23 Note: Nevro raised $36 million...
Read More
BioCentury | Jun 8, 2015
Financial News

Nevro completes follow-on

Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date completed: 2015-06-03 Type: Follow-on Raised: $90 million Shares: 1.8 million Price: $51 Shares after offering: 26.7 million Underwriters: JPMorgan; Morgan Stanley; Leerink Partners; JMP Securities Overallotment:...
Read More
BioCentury | May 25, 2015
Financial News

Nevro proposes follow-on

Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date announced: 2015-05-18 Type: Follow-on To be raised: $75 million Shares: TBD Price prior: $53.12 Underwriters: JPMorgan; Morgan Stanley; Leerink Partners; JMP Securities Overallotment: $30 million Note:...
Read More
BioCentury | Nov 23, 2009
Company News

Neuros Medical management update

...Inc. , Cleveland, Ohio Business: Neurology Hired: Zi-Ping Fang as CTO, formerly chief scientist at Nevro Corp. WIR...
Read More
Items per page:
1 - 6 of 6